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Abstract
Background: Little is understood of the molecular mechanisms involved in the earliest cell fate decision in human
development, leading to the establishment of the trophectoderm (TE) and inner cell mass (ICM) stem cell
population. Notably, there is a lack of understanding of how transcriptional networks arise during reorganisation of
the embryonic genome post-fertilisation.
Results: We identified a hierarchical structure of preimplantation gene network modules around the time of
embryonic genome activation (EGA). Using network models along with eukaryotic initiation factor (EIF) and
epigenetic-associated gene expression we defined two sets of blastomeres that exhibited diverging tendencies
towards ICM or TE. Analysis of the developmental networks demonstrated stage specific EIF expression and
revealed that histone modifications may be an important epigenetic regulatory mechanism in preimplantation
human embryos. Comparison to published RNAseq data confirmed that during EGA the individual 8-cell
blastomeres are transcriptionally primed for the first lineage decision in development towards ICM or TE.
Conclusions: Using multiple systems biology approaches to compare developmental stages in the early human
embryo with single cell transcript data from blastomeres, we have shown that blastomeres considered to be
totipotent are not transcriptionally equivalent. Furthermore we have linked the developmental interactome to
individual blastomeres and to later cell lineage. This has clinical implications for understanding the impact of fertility
treatments and developmental programming of long term health.
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Background
The preimplantation period is a unique window in de-
velopment, when extensive remodelling of the genome
and epigenome occur over the few days that the embryo
is a free-living entity. This window is of critical import-
ance allowing the fertilised oocyte to (i) correctly repro-
gram the male genome and activate the new embryonic
genome, (ii) substantially reset the epigenome via a
process that includes generalised demethylation and
remethylation, and (iii) establish the first cell fate deci-
sion in development towards formation of the troph-
ectoderm (TE), while maintaining the inner cell mass
(ICM) stem cell population [1–3].
The processes underlying some of the key molecular
and cellular decisions are not fully understood, including
Embryonic Genome Activation (EGA), mechanisms
underlying epigenome remodelling, and cell fate deci-
sions governing blastomere development and differenti-
ation into the ICM or trophectoderm (TE) tissues of the
blastocyst. Early embryos inherit stored mRNA and pro-
teins from the oocyte which guide development under
maternal control until EGA. The degradation of particu-
lar inherited mRNAs may itself regulate the timing of
EGA [4]. The start of EGA in the human was originally
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defined as occurring between the 4-cell and 8-cell stage
[5]. However more recent studies have suggested that
there are in fact three waves of EGA, occurring at the 2
cell, 4-cell and 8–10 cell stages, with the final represent-
ing the highest level of transcriptional activity [6]. Epi-
genetic remodelling in the human embryo occurs post
fertilisation, with embryonic DNA generally demethy-
lated to 30–40% by the 2-cell stage, with minimal subse-
quent loss of methylation, and no re-methylation until
the post-implantation stages [7]. During this period of
intensive remodelling, cell fate decisions are initiated
which lead to segregation of human ICM and TE. It is
currently unknown as to whether individual blastomeres
from 8-cell embryos are pre-determined to become ICM
or TE, but it is known that considerable heterogeneity
exists between blastomeres at this point, due in part to
the absence of gap junctional communication prior to
this stage [8, 9]. The reported variation in different tran-
script subsets between individual human 8-cell blasto-
meres has been interpreted as indicating that some may
arrest whilst others develop [10]. In particular, individual
8-cell blastomeres were reported to display significant
variation in down-regulation of maternally-expressed
genes, which may indicate early lineage specification. In
contrast, other studies have shown that blastomeres
from 5- to 8-cell human embryos are not
pre-determined to become either ICM or TE [11]. We
hypothesised that an analysis of the global human
embryo transcriptome using a combination of network
analyses, dimensional scaling and change point analysis
would allow us to identify the transcriptional
co-ordination involved in the key early developmental
event of blastomere cell fate specification.
Methods
Oocytes and embryos
Human oocytes and embryos were donated to research
with fully informed patient consent in writing and ap-
proval from South Manchester Research Ethics Commit-
tee under Human Fertility and Embryology Authority
research licence R0026. Fresh oocytes and embryos sur-
plus to the clinical IVF treatment programme were ob-
tained from Saint Mary’s Hospital Manchester, graded
and prepared as described in Shaw et al 2013 [12]
(Fig. 1a).
Embryo sample preparation and microarray analysis of
transcriptome
Upon donation to research, embryos were cultured in
G1 medium (Vitrolife, Goteborg, Sweden) covered with
a thin layer of mineral oil (Ovoil, Origio, Malov,
Denmark) until day 3, followed by G2 medium (Vitro-
life) from day 3 to blastocyst at 37 °C, 6% CO2 in a hu-
midified atmosphere. Oocytes and embryos at a range of
developmental stages, including four oocytes, four 4-cell
embryos, three 8-cell embryos, 32 individual blastomeres
Fig. 1 Schematic representing the human embryonic stages analysed and transcriptomic comparisons. a) The human embryonic stages analysed.
We carried out single embryo and blastomere polyA-PCR global transcriptome profiling on replicate oocytes and embryos at the 4-cell (n = 4), 8-
cell (n = 3) and blastocyst (n = 4) stage, together with 8 individual blastomeres disaggregated from one 8-cell embryo, and trophectoderm (n = 4)
and inner cell mass (n = 4) disaggregated from blastocysts. We carried out single embryo and blastomere polyA PCR and qPCR on 24 individual
blastomeres disaggregated from 3 complete sets. 8 individual blastomeres were used for qPCR validation. b) Different transcriptomic comparisons
applied throughout the paper. To determine differences in gene expression between samples ANOVA was performed on 4-cell embryos vs.
oocytes, 8-cell embryos and blastocysts. Benjamini-Hochberg false discovery rate (FDR) corrected p-values ≤0.05 were considered differentially
expressed. Frozen robust multi-array analysis (fRMA) was used to define absolute expression by comparison to publically available microarray
datasets within R and an expression barcode was defined for the 8-cell blastomere, ICM and TE sample
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obtained from four eight cell embryos (blastomeres) and
four blastocysts were lysed and reverse transcribed as
previously described [8, 13] and cDNA was prepared by
polyA-PCR amplification [14]. Embryos were only used
if they both reached the appropriate development stage
for time in culture and were morphologically normal. Of
the 32 8-cell blastomeres, 8 disaggregated from a single
8-cell stage embryo were used to generate single cell
transcriptomic data, the remaining 24 disaggregated
from 3 complete sets of 8 individual blastomeres were
used for qPCR validation. 8-cell stage embryos used for
blastomere isolation were equivalent in stage and ap-
pearance to those used for single embryo analysis and,
to further reduce bias, we analysed only blastomere sets
in which we recovered all 8 blastomeres from an 8-cell
embryo. For blastomere disaggregation, whole embryos
were exposed to Acid Tyrode’s Solution (Sigma) for ~ 3 s
intervals until zona breakdown occurred and individual
blastomeres were isolated via mechanical disaggregation.
The polyA-PCR technique amplifies all polyadenylated
RNA in a given sample, preserving the relative abundance
in the original sample [15, 16]. A second round of amplifi-
cation using EpiAmp (Epistem, Manchester, UK) and
biotin-16-dUTP labelling using EpiLabel (Epistem) was
performed at the Paterson Cancer Research Institute
Microarray facility, as previously described [12]. For each
sample, our minimum inclusion criterion was the expres-
sion of β-actin evaluated by gene specific PCR. Labelled
PolyA-cDNA was hybridised to the GeneChip® Human
Genome U133 Plus 2.0 Array (Affymetrix, SantaClara,
CA, USA) and data initially visualised using MIAMIVICE
software [12]. The statistical and graphical R computing
language was used together with Bioconductor packages
[17, 18], to assess quality control of microarray data (Array
Quality Metrics package) [19] (Additional file 1: Supple-
mentary Methods and Additional file 2: Figure S1) and
normalisation undertaken using the Mas5 algorithm [20].
Principal component analysis (PCA) was conducted using
Partek Genomics Suite software (St. Louis, MO, USA),
with IsoMap cross-validation undertaken using Qlucore
Omics Explorer 2.3 (Qlucore, Lund, Sweden).
Differential gene expression was determined using
ANOVA (Fig. 1b). Benjamini-Hochberg false discovery
rate (FDR) corrected p-values ≤0.05 were considered dif-
ferentially expressed [21]. Genes were defined as
expressed at a particular developmental stage if present in
at least 75% (or two of three) samples (Additional file 3:
Table S1). Normalised eukaryotic initiation factor (EIF)
family member expression levels were extracted from the
arrays for relative expression across development.
Quantitative PCR
Gene specific PCR amplification of a panel of pluripo-
tency, polarity and hippo-signalling genes was assessed
by qPCR using Power SYBR Green Master Mix (Applied
Biosystems) according to the manufacturer’s instruc-
tions. Primers were designed to produce a product be-
tween 50 and 200 base pairs within the first 500 base
pairs of the gene to prevent amplification bias. Each
10 μl reaction contained 2 ng polyA-cDNA template and
the cycling was performed in an ABI 7300 real-time
PCR system. A 10min denaturation step at 95 °C was
followed by 39 PCR cycles comprising 30s denaturation
at 95 °C, 30s annealing at 60 °C and 35 s extension at 72 °
C. An extended annealing step of 10 min at 72 °C fina-
lised the run. Identification of a single peak at melt
curve analysis signified gene expression. Reactions were
performed in triplicate for each individual sample. ΔCt
was calculated as 40-Ct value for data presentation pur-
poses. Some samples showed low levels of gene expres-
sion however genes were not classed as ‘expressed’
above background level unless detected with 37 or fewer
cycles of real-time PCR. We only included a sample in
the analysis data set if greater than 3 target genes were
defined as expressed. Associations between expressed
genes were analysed for significance using a chi squared
test. Genes displaying p ≤ 0.05 were defined as differen-
tially regulated.
Networks of genes associated with embryonic
development
We generated human protein-protein interaction (PPI)
networks based on differentially expressed genes in Cytos-
cape [22] by inference of protein: protein interactions
using the BioGrid database [23] with the BioGrid Plugin
for Cytoscape [24]. This network generation approach
uses a process of inference where a minimum number of
connecting proteins are added between proteins with dif-
ferential gene expression to form a fully connected PPI
network model. As a result we capture a section of the hu-
man interactome that is associated with transcriptomic
differences. Networks enriched for differentially expressed
genes were constructed for each developmental stage. The
Cytoscape plugin Moduland [25] was used to identify
overlapping modules of protein:protein interactions within
each developmental network and modular hierarchy was
determined using the centrality score (a quantitative
measurement of proximity to the centre of the network –
the more central a protein is the more it can influence the
effect of all other proteins in the network).
Epigenetic regulator genes were compiled from the
Qiagen Epigenetic Chromatin Remodelling Factors PCR
array (Qiagen) and the Epigenetic Modification Enzymes
PCR array (Qiagen), supplemented with genes identified
by the network analysis with a known epigenetic role. A
hypergeometric distribution was applied to assess en-
richment of individual 8-cell blastomeres for chromatin
modification enzymes/remodelling factors. Causal
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Networks (Z-scores >І2І) were used to assess regulatory
elements within the networks [26] (Ingenuity Pathway
Analysis [IPA], Qiagen).
Gene expression barcoding of individual 8-cell
blastomeres
Frozen robust multi-array analysis (fRMA) [27] was used
to define absolute expression by comparison to publi-
cally available microarray datasets within R and an ex-
pression barcode was defined for each specific tissue and
cell type [28, 29]. This GeneBarcode was used to gener-
ate single sample networks for the individual blasto-
meres. Using GeneBarcode, we considered transcripts
expressed in 2–5 blastomeres, resulting in 5044 genes
for downstream analysis.
Change point analysis of developmental gene expression
Our embryonic development transcriptomic data (Oo-
cyte, 4-cell, 8-cell and Blastocyst) were filtered by using
PCA analysis (Qlucore Omics Explorer 2.3), and 1676
probes were selected with a 1.2 cut-off for the projection
score [30]. Then change point analysis was performed in
order to identify times in embryonic development when
there was a distinct shift in the distribution of gene ex-
pression, using the “changepoint” package [31] within R
[17]. The transcript expression levels across the stages
between two change points were replaced by the average
value within this interval and the transcripts were then
clustered using hierarchical clustering.
RNAseq analysis
We analysed previously published single-cell RNAseq data
from 81 individual 8-cell human blastomeres [32]. Tran-
scripts per million (TPM) expression values were visua-
lised in Qlucore Omics Explorer 2.3 and outliers were
removed. These were normalised for inter-individual vari-
ation (mean centred by the embryo donor couple) and by
application of a projection score [30] of 0.21 to remove
noise (n = 59). Gene sets identified were analysed for Gene
Ontology and Canonical pathway enrichment using DA-
VID [33] and mapped onto our differentially regulated
8-cell blastomere network modules.
Results
Hierarchy of network modules across embryo
development
We carried out single embryo and blastomere
polyA-PCR, global transcriptome profiling on replicate
oocytes (n = 4) and embryos at the 4-cell (n = 4), 8-cell
(n = 3) and blastocyst (n = 4) stage, together with 8 indi-
vidual blastomeres disagregated from one 8-cell embryo
(Figs. 1, 2a). PCA analysis revealed that the intact 8-cell
embryos and the individual 8-cell blastomeres demon-
strated overlapping transcriptomes (Fig. 2a), indicating
that the embryo disaggregation procedure for isolating
blastomeres had not significantly altered the blasto-
meres’ expression profiles.
Over the developmental series of embryonic stages we
identified 7 key transitions in differentially expressed
gene probe-sets using change point analysis (Fig. 2b).
Genes expressed in the oocyte and 4-cell embryo but
not subsequently (Changepoint group 7; CP7) were con-
sidered to be maternally expressed only, those expressed
in the oocyte and subsequently at 8-cell (CP6), or oo-
cyte/4-cell and subsequently at blastocyst (CP1), were
considered to be expressed both maternally and embry-
onically following EGA, while those not expressed in the
oocyte but only at subsequent stages were assumed to
reflect EGA at early (CP3), mid (CP4 and CP5) and late
(CP2) developmental stages. The gene ontology associ-
ated with each change point group was determined
(Additional file 3: Table S2).
Gene networks of the transition for each embryonic
stage were constructed by inference to the human inter-
actome network (BioGRID version 3.2.110) (Additional
file 2: Figure S2A and B) and a hierarchy of gene mod-
ules were defined using the topological property of cen-
trality (Additional file 2: Figures S2C and D).
Overlapping network modules were identified and cen-
trally connected genes were used to assess the crosstalk
between modules (Additional file 2: Figure S2E and F).
We tracked centrally connected genes across our human
embryo samples, highlighting features which are main-
tained throughout development or unique to a certain
embryonic stage (Fig. 2c).
Modules expressed in embryos post-EGA, or conserved
in both the 8-cell and blastocyst, were deemed to reflect
transcription following early and/or later EGA in prepar-
ation for implantation and continuing development (Fig.
2a). Definition of network modules in the 8-cell embryo
and blastocyst (Additional file 2: Figure S2A-D) were used
as a basis to identify upstream regulatory elements (Add-
itional file 2: Figure S2E and F). This approach revealed
relationships between TRIM28/KAP1, MDM2, HDAC2
and TP53 and the networks of genes they regulate to be of
central importance during 8-cell to blastocyst develop-
ment (Additional file 1: Supplementary results, Additional
file 3: Table S3, Additional file 2: Figure S3). Network
models defined using inference to the human interactome
were confirmed and the robustness of the identified gene
modules were assessed by comparison to co-expression
networks (Additional file 2: Figure S4).
Mapping TE or ICM gene expression signatures to
individual 8-cell blastomeres
We defined the transcriptional signatures underlying
maintenance of pluripotency and cell lineage separation
in the human embryo by comparing the transcriptomes
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Fig. 2 Embryonic transcriptomic profiles. a) Principle Component Analysis (PCA) of Mas5 normalised expression values across the human
embryonic developmental stages, four oocytes (orange), four 4-cell embryos (red), three whole 8-cell embryos (green), eight 8-cell blastomeres
(blue) and four blastocysts (purple). Ellipsoids represent variation within a specific developmental stage. b) Heat map of change point matrix for
developmental series displayed in panel A. Red represents increased expression and blue decreased expression. c) Overlap of network modules
across human embryo development. The top 15 modules are extracted from each developmental stage networks and listed in hierarchical order
from (1st) most central in the network to (15th) less centrally connected in the network. The gene labelled on the module represents the most
centrally connected gene within the module. Blue lines indicate modules which have > 2 shared members between the different developmental
stages and the thicker the line the greater the number of shared genes. Modules outlined in red have no shared central elements with the
following or preceding developmental stage
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of individual 8-cell blastomeres (B1-B8, Fig. 3). From
these data we constructed interaction networks for each
blastomere to reveal a hierarchy of modules of highly
connected genes (Fig. 3a). We identified upstream regu-
latory patterns for each blastomere and overlaid the up-
stream regulatory genes onto blastomere network
modules (Additional file 2: Figure S5); the high level of
overlap (p-value range 0.01–1.2 × 10− 23) provided confi-
dence in our gene identifications. Module similarity be-
tween the blastomeres was visualised via connectivity in
circos plots based on the degree of module overlap
(shared ≥5 genes) (Fig. 3b). B4 and B8 were less similar
to other blastomeres, whilst B1 shared the greatest
amount of similarity to other blastomeres, in particular
B3, B5 and B7 (Fig. 3c).
To assess if the differences between the blastomeres
represented transcriptional priming towards either ICM
or TE lineage, we repeated the same analysis with the in-
clusion of TE (n = 5) and ICM (n = 5) samples (from Ste-
vens et al 2018 [34]) (Fig. 3d). Based on the degree of
module overlap (shared ≥5 genes), 5 blastomeres are
similar to the ICM, B1, B5 and B6 showed statistically
significant overlap (p-value range 8.6 × 10− 22 to 2.4 ×
10− 82). To verify our circos plots, we visualised the
blastomere, TE and ICM global expression profiles using
IsoMap dimensional scaling (Fig. 3e). These analyses re-
vealed similarities in global gene expression between
blastomere B3, B4, B7, B1, B6 and B5 with ICM, and
blastomere B8 and B2 with TE, providing independent
validation of the overlaps shown in the network derived
circos plot and indicating that the TE expression profile
was similar to B2, B5 and B8. B2 was therefore identified
as TE-like in all three independent analyses, suggesting
that blastomere cell fate may be primed at this stage.
8-cell blastomeres are not transcriptionally equivalent
In order to explore blastomere cell fate and potential
mechanisms in more detail we carried out single embryo
and blastomere polyA-PCR and qPCR on a further 24
individual blastomeres disaggregated from 3 complete
sets of 8 individual blastomeres. We screened for the ex-
pression of genes associated with the Hippo signalling
pathway which is involved in specifying TE cell fate [35]
(LATS2, YAP, TEAD4, TAZ, CDX2), cell polarity [36]
(PARD3, PARD6A, EZRIN, PRICKLE2 and CDX2) and
cell pluripotency [37] (SOX2 and OCT4) (Additional file
2: Figure S6). No embryo was devoid of LATS2, with ex-
pression detected within at least 2 of the 8-cell blasto-
meres. The blastomeres lacking LATS2 but expressing
TAZ/YAP, TEAD4 and CDX2 may have greater potential
to give rise to future TE. EZRIN was the only polarity
gene expressed in the majority of 8-cell blastomeres;
however levels of expression varied greatly between indi-
vidual cells. We observed no clustering of gene
expression by embryo and the differences in expression
of genes involved in hippo signalling, polarity and pluri-
potency pathways between the individual blastomeres
verified the finding from whole transcriptome data that
8-cell blastomeres were not transcriptionally equivalent.
Expression of eukaryotic initiation factors (EIFs) at the
time of EGA
Expression and activity of EIFs is critical to successful
EGA [38]. Whole transcriptome gene expression of the
EIF family was significantly upregulated in the 8-cell and
blastocyst (Fig. 4a) and this expression pattern closely
followed the general wave of transcripts initiated during
EGA [39]. Altogether, 45 EIFs were expressed during
pre-implantation development (Fig. 4a). Nineteen EIFs
were differentially regulated between the 8-cell embryo
and blastocyst; EIF2S2, EIF3I, and EIF43M are up-regu-
lated at the 8-cell, EIF4E, EIF4E2 and EIF4G2 are
up-regulated in the blastocyst (with EIF4E, EIFE2 and
EIFG3 regulated by the TRIM28 network, Additional
file 2: Figure S3A), and EIF4A3 was upregulated in
the 8-cell embryo compared to both the 4-cell and
blastocyst stage embryo (all FDR modified p-value
≤0.05) (Fig. 4b).
The role of EGA in blastomere identity was assessed
by examining that transcriptome of individual 8-cell
blastomeres to reveal if they displayed varying levels of
EIFs. Half of the EIFs differentially regulated in the
8-cell embryo and blastocyst, were present in all individ-
ual 8-cell blastomeres, including the 8-cell-specific
EIF4A3. However the remaining EIFs displayed varying
expression levels, with B1 expressing all (10/10) of these
EIFs and B2 (3/10) and B8 (5/10) expressing the least
number of EIF family members (Fig. 4c).
Enriched epigenetic signature at the 8-cell stage
As epigenetic modifier genes such as TRIM28 were dif-
ferentially expressed during preimplantation develop-
ment (Additional file 2: Figure S3A), we constructed
networks of chromatin modifying enzymes/remodelling
factors (Additional file 3: Table S4). More Epigenetic
regulatory genes were expressed in the 8-cell embryo
(102 genes) compared to the blastocyst (40 genes). Only
two genes, HDAC2 and YY1, were upregulated at both
stages compared to the 4-cell embryo. Both of these
genes were identified as key 8-cell and blastocyst net-
work members (Additional file 2: Figure S2E and F).
HDAC2 is a downstream target of the blastocyst
TRIM28 network (Additional file 2: Figure S3A), whilst
YY1 is a centrally connected gene (Additional file 2: Fig-
ure S2C and D) in the 8-cell and blastocyst embryo.
Overall, the larger subset of histone acetyltransferases,
methyltransferases and deacetylases identified in the
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8-cell embryo, indicated that these genes play a part in
epigenetic remodelling at this stage.
Due to the upregulated epigenetic-associated gene ex-
pression at the 8-cell stage, we assessed the expression
of epigenetic regulatory genes within the individual
8-cell blastomeres (Fig. 5). Individual 8-cell blastomeres
were significantly enriched (P < 3.4 × 10− 20) for chroma-
tin modification enzymes and remodelling factors.
TRIM28 network genes, HDAC2 and ZSCAN4 were
expressed in all blastomeres. However global epigenetic
gene expression patterns revealed two groups of individ-
ual 8-cell blastomeres; B3/B4/B6, and B1/B2/B5/B7/B8.
Comparison to published single blastomere RNAseq data
To validate and extend our findings of blastomere tran-
scriptional heterogeneity, we analysed single-cell RNA-
seq data from 81 individual 8-cell human blastomeres
[32]. After outlier removal, 59/81 published blastomere
datasets of high quality (embryos in which ≥4 of the 8
blastomeres were recovered) were used in further ana-
lysis. A PCA of the remaining blastomeres highlighted
that the greatest variation in gene expression existed be-
tween the individual embryos rather than the individual
blastomeres (Fig. 6a). Once samples were normalised for
inter-embryo variation we were able to detect differences
between individual blastomeres regardless of their em-
bryo origin (Fig. 6b). We identified the presence of 4 sets
of genes; of which group 3 was enriched (p = 0.0012) for
Pluripotency of Embryonic Stem Cells (Additional file 1:
Supplementary Results, Additional file 2: Figure S7 and
Additional file 3: Table S5).
Discussion
Although there is an increasing body of information
about preimplantation human development, relatively
little is understood of molecular mechanisms and in par-
ticular there is little quantitative information on regula-
tory gene networks governing the first cell fate decisions
in development. Our analysis extends understanding in
this area significantly by identifying gene networks in-
volved in EGA and blastomere transcriptional identity
and cell fate (Fig. 7).
Gene networks involved in development during EGA
In humans the major wave of EGA occurs between the
4-cell and 8-cell stage [5, 6], although the mechanisms
by which this activation is translated into downstream
regulation of embryonic development are unclear. We
identified 7 distinct patterns of expression in the human
embryonic transcriptome corresponding to different
early or late patterns around the time of EGA.
Eukaryotic initiation factors (EIFs) are closely associated
with transcription activation in mammalian development
[40]. We report here a pattern of EIF expression which
closely follows EGA, and may be responsible for trans-
lating its impact. EIF expression peaked in the 8-cell em-
bryo, which agrees with data of Vasenna et al, who
identified three waves of transcriptional activation in
humans; the last wave occurring at the 6 to 8-cell stage
being responsible for the transcription of the largest
number of genes [6]. EIF2S2, EIF3I, and EIF4M are
up-regulated in the 8-cell embryo, with only EIF2S2 hav-
ing been previously detected in hESCs and mESCs [41].
EIF expression and activity seems likely to be one of the
main mechanisms driving expression of the embryonic
developmental programme post-EGA.
Using multiple methods of analysis provides a high con-
fidence framework for understanding the relationship be-
tween gene networks at different stages of human
preimplantation development. This revealed that
TRIM28/KAP1, MDM2, HDAC2 and TP53 and the net-
works of genes they regulate are of central importance at
the 8-cell to blastocyst transition. TRIM28 recruits chro-
matin modification enzymes and remodelling factors to
form a repressive chromatin complex and its expression is
essential in mice [42]. We report that TRIM28 controls a
central network of 46 genes, regulating MYC, TP53 and
MDM2, suggesting this is essential in embryonic develop-
ment across species, including humans.
Our analysis showed that genes involved in epigenetic
regulation were enriched during late EGA. This expres-
sion coincides with the highly transient period of genomic
and epigenomic reorganisation [43–46]. We observed the
greatest epigenetic signature enrichment in the 8-cell em-
bryo, with more histone deacetylases, methyltransferase
and demethylases expressed than DNA methyltransferases
and demethylases. DNA modifications are thought to be
(See figure on previous page.)
Fig. 3 Comparison of individual 8-cell blastomere, inner cell mass (ICM) and trophectoderm (TE) network modules. a) Schematic of methodology.
Frozen robust multi-array analysis (fRMA) was used to define absolute expression by comparison to publically available microarray datasets within
R and an expression barcode was defined for each cell. This GeneBarcode was used to generate single sample networks and identify modules for
the individual blastomere samples. Blastomere module similarity was visualised using circos plots. b) Individual 8-cell blastomere module
similarity. Similar modules between pairs of blastomeres are tabulated and visually represented by connections on circos plots. Similar modules
have ≥5 genes. c) Tabulated circos plot. Colours of blastomeres represent groups of similarity. The total column shows total overlap in modules
for each blastomere, indicating B4 and B8 are the least similar to others. d) Individual 8-cell blastomeres, ICM (n = 5) and TE (n = 5) module
similarity (≥5 genes per module). e) Nearest neighbour PCA analysis (isoMap) reveals similarity of individual 8-cell blastomeres (green), TE (red)
and ICM (blue)
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Fig. 4 Eukaryotic Initiation Factor (EIF) expression across embryo development and the individual 8-cell blastomeres a) Heat Map to represent the
45 EIFs expressed constitutively within at least one oocyte or embryonic stage. Mas5 flags with 75% expression within a specific developmental
stage are classed as expressed. b) Schematic indicating differentially expressed EIFs (Benjamini-Hochberg FDR≤ 0.05) between the 4-cell embryo,
8-cell embryo and blastocyst. c) Frozen robust multi-array analysis (fRMA) was used to define absolute expression by comparison to publically
available microarray datasets within R and an expression barcode was defined for each 8-cell blastomere. The heat map represent EIFs expression
within individual 8-cell blastomere expression barcode data, genes with a score of ‘1’ are present and ‘0’ are absent. Half of the EIFs associated
with EGA are expressed in all 8 blastomeres, the other half are variably expressed, with blastomere B1 expressing the full complement (10/10),
while B2 expressed the fewest (3), with B8 expressing 5/10
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the main form of epigenetic regulation applied later in de-
velopment when cells differentiate into particular cell
types and genes exhibit long term repression, whereas his-
tone modifications are the major form of gene silencing in
early differentiation [45]. The removal of histone modifi-
cations is enzymatically easy and so may be preferable
during dynamic periods of genome reorganisation,
whereas removal of such groups from DNA carry the risk
of deleterious DNA mutations. Our analysis of transcrip-
tomic data suggest that in the preimplantation human em-
bryo histone modifications may be the main epigenetic
regulatory mechanism during the transient and dynamic
period of genome reorganisation. Although, of course,
protein synthesis and activity of epigenetic regulators may
not necessarily follow transcript expression and further
epigenomic analysis would be required to confirm this
observation. However, modifications to the epigenome are
closely correlated with the transcriptome in developing
systems [47]. Epigenetic regulatory networks and chroma-
tin modifying genes in particular were expressed at the
8-cell stage, and in light of their potential role in gene si-
lencing, we explored their association with blastomere
identity. Epigenetic gene expression patterns revealed two
groups of 8-cell blastomeres (Fig. 7).
Networks involved in 8 cell blastomere identity and fate
To understand the molecular mechanisms by which in-
dividual 8-cell blastomeres achieve diverging cellular
identities and either retain pluripotency or differentiate
towards TE, we assessed the transcriptome of individual
8-cell stage blastomeres using gene network analyses. It
has been previously shown that blastomeres have
Fig. 5 Chromatin modification enzymes/remodelling factors gene expression barcode data within individual 8-cell blastomeres. Frozen robust
multi-array analysis (fRMA) was used to define absolute expression by comparison to publically available microarray datasets within R and an
expression barcode was defined for each 8-cell blastomere. The heat map represents gene expression within individual 8-cell blastomeres
expression barcode data, genes with a score of ‘1’ are present and ‘0’ are absent. The global epigenetic gene expression pattern reveals two
groups of individual 8-cell blastomeres; B3/B4/B6 and B1/B2/B5/B7/B8
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Fig. 6 Individual 8 cell blastomere RNA-Seq data (from Petropoulos et al). Transcripts per million (TPM) expression values were visualised using
principal component analysis (PCA) and outliers were removed. After outlier removal we used 59 of the 81 published samples. a) PCA
representing the expression of individual 8-cell blastomeres coloured according to the individual 8-cell embryo of origin. b) PCA of 8-cell
blastomeres normalised for embryo of origin and variance filtered by application of a projection score of 0.21 to remove noise
Fig. 7 Summary schematic representing 8-cell blastomere genomic divergence. Using a combination of systems biology techniques including
network analysis, nearest neighbour PCA (isoMap), EIF expression and epigenetic-associated gene expression we have detected two sets of
blastomeres within an 8-cell embryo which exhibit diverging tendencies towards ICM and TE. Nearest neighbour PCA analysis (isoMap) reveals
similarities in global gene expression between blastomere 3, 4, 7, 1, 6 and 5 with Inner Cell Mass (Blue brackets/arrows), and blastomere 8 and 2
with Trophectoderm (burgundy brackets/arrows). Green arrows represent similarity in network modules, as highlighted by circos plots. Black
bracketed Blastomere 3, 7 and 8 are enriched in RNAseq cluster 3 and Blastomere 6, 5 and 8 are enriched in RNAseq cluster 1. Red brackets/
arrows represent blastomeres with the greatest maintenance and loss of developmental EIF expression. B3, B4 and B6 (red coloured blastomeres)
have distinct epigenetic associated gene expression signatures from those expressed by blastomeres B1, B2, B5, B7 and B8 (blue blastomeres)
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different transcriptional [48–50] and epigenomic iden-
tities [51]. In this manuscript we have defined the rela-
tionship with respect to both the global transcriptome
and to gene families involved in specifying cell fate. Ana-
lysis of genes involved in the hippo signalling pathway,
cell polarity and pluripotency showed that no individual
blastomere exhibited an identical expression profile to
any other blastomere within the same embryo or to
those of other 8-cell embryos. The generation of single
sample networks for the individual blastomeres global
transcriptomes allowed us to quantify the differences/
similarities in modules between blastomeres and to map
these with high confidence to the embryonic develop-
mental interactomes identified earlier. Groups of blasto-
meres were identified as more or less similar to each
other, and to global transcriptomes of ICM and/or TE
which may represent transcriptional priming towards
one or other lineage (Fig. 7).
We examined if the developmental changes identified
around the time of EGA mapped onto the blastomere
transcriptome, i.e. is blastomere transcriptional identity
driven by EGA? The EIF family genes involved in translat-
ing EGA expression, revealed a close relationship with
blastomere identity. Half of the post-EGA differentially
expressed EIFs displayed disparate expression, with blasto-
mere B1 expressing all EIFs and blastomere B2 and B8 ex-
pressing the least EIFs, suggesting that loss of EIFs may be
a potential first point of differentiation [9, 12].
We accounted for more variation in the data by the
application of dimensionality reduction techniques (PCA
and IsoMap), which demonstrated a direct relationship
between the global transcriptomic profiles of six blasto-
meres with ICM, of which all but B3 show differentially
regulated network module similarities to ICM (Fig. 7).
IsoMap also identified a direct relationship in the global
genetic profiles of blastomeres B8 and B2 with TE, and
blastomere B2 showed differentially regulated network
module similarities to TE.
The network approaches used in this work are resist-
ant to random error due to the scale free nature of the
interactome [52] and therefore form a good basis for the
comparison of blastomeres where inter individual vari-
ation has been recognised. A similar separation of the
blastomeres is apparent after comparison to the most
detailed publicly available RNAseq dataset from Petro-
poulos et al [32]. Overall, the blastomeres enriched in
the Petropoulos RNAseq group 3 genes have a stronger
divergence towards ICM, whereas the blastomeres
enriched in RNAseq group 1 genes have no particular
lineage bias (Fig. 7). Having established the likely tran-
scriptional bias of blastomeres towards ICM or TE, we
further suggest that the pluripotent state leading to ICM
is associated with maintenance of EIF expression, and
epigenetic status.
Clinical implications
We have applied a combination of systems biology ap-
proaches to identify a high confidence framework of hu-
man preimplantation embryonic networks focussed on
EGA and its relationship to blastomere cell fate. This will
be uniquely valuable for understanding early human de-
velopment, where classical experimental design cannot be
easily applied due to the rare and protected nature of hu-
man embryos. Moreover our gene regulatory framework
highlights points of susceptibility during human embryo
development, particularly around gene networks involved
in EGA and blastomere fate. This provides the scientific
community with the opportunity to explore the mecha-
nisms underlying early programming of development,
long term health e.g. according to the Developmental Ori-
gins of Health and Disease (DOHaD), and a baseline of
normal development against which ART practitioners can
assess the impact of new clinical technologies [53, 54].
Conclusions
Utilising multiple layers of computational evidence, we
have detected two sets of blastomeres within an 8-cell
embryo which exhibit diverging tendencies towards ICM
and TE (Fig. 7). Overall our results suggest that the ma-
jority of blastomeres are still pluripotent and are unlikely
to be lineage-specified or committed. This observation
agrees with previous studies indicating that 5–8 cell
blastomeres showed equal expression in all ICM,
stem-ness and TE markers [11], and with RNAseq data,
revealing relatively little transcriptional divergence at the
8-cell stage [32]. However we have identified signifi-
cantly more heterogeneity between blastomeres than has
been previously reported and through the application of
our network module approach we have detected bio-
logically significant biases with functional relevance
which may prime cells for the earliest cell fate determin-
ation. Our approach allows a greater depth of predicted
functional analysis than other previously used single di-
mensional approaches.
Additional files
Additional file 1: Supplemental Methods and results (DOCX 3560 kb)
Additional file 2: Figure S1. Un-normalised Affymetrix microarrays A)
Boxplots represent summaries of the signal intensity distributions of the
arrays. Each box corresponds to one array. B) Boxplot outlier detection
was performed by computing the Kolmogorov-Smirnov statistic Ka-
between each array’s distribution and the distribution of the pooled
data. None of the samples have medians higher than 1.05, which would
represent a low quality array C) Density distributions of the log2-
intensities grouped by the matching type of the probes. The blue line
shows a density estimate (smoothed histogram) from intensities of
perfect match probes (PM), the grey line, one from the mismatch
probes (MM). D) RNA digestion plot. The shown values are computed
from the pre-processed data. Each array is represented by a single line.
E) MA plots (M = log2 (I1)-log2 (I2), A = 1/2(log2 (I1) + log2 (I2)), where I1 is
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the intensity of the array studied, and I2 is the intensity of a “pseudo”-array that
consists of the median across arrays. The mass of the distribution in an MA
plot should be concentrated along the M= 0 axis, and there should be no
trend in M as a function of A. Shown are first the 4 arrays with the highest
values of Da, then the 4 arrays with the lowest values. F) An example of feature
intensities representing the arrays’ spatial distributions (M). Figure S2. A and B)
Embryonic genome activation (EGA) interaction networks, differential
regulation within the 8-cell and blastocyst compared to the 4-cell. C and D)
Metanodes of the 8-cell and blastocyst compared to the 4-cell, metanodes as
defined by the Cytoscape plugin ‘Moduland’, metanodes represent genes
most central within each module. Red genes represent up-regulation, green
nodes represent down-regulation and pink nodes represent non-differentially
regulated genes but baseline expressed direct interaction partners. E and F)
Tables of network module members. Metanodes represent the most centrally
connected gene within a module alongside the next 10 centrally connected
genes within each module. Modules are ranked in order from most to least
centrally connected within the specific developmental network. Yellow
highlighted genes are also identified as Ingenuity causal network genes.
Figure S3. A) TRIM28 upstream regulatory network in blastocysts. MDM2 is
the only target gene regulated by both upstream regulators MYC and TP53.
TRIM28 together with MYC and TP53, may represent the upstream
transcriptional control network over the MDM2 module in the blastocyst and
provide upstream regulation of epigenetic networks. B) MDM2 is identified as
a key module and upstream regulator at the blastocyst stage. MDM2 together
with 22 participating regulators, controls the expression of 93 differentially
regulated genes within the blastocyst. The participating regulator, transcription
factor GATA3, is up-regulated 867-fold in the blastocyst. Pink nodes represent
genes identified within module analysis and red nodes represent genes
identified within both module and upstream regulatory network analysis.
Pathway analysis of the MDM2 module reveals statistically over-represented
(p ≤ 0.05) Reactome pathways, ordered from 1 to 10 according to their
significance p-value. The MDM2 module is biologically relevant, with 6/10 of
the top MDM2 module genes being members of the hedgehog signalling ‘on
state’ pathway. Figure S4. A) 107 co-expression functional modules B) The
frequency a module of a specific size was detected using co-expression
analysis. C) Overlap of the intra-modular hubs between different methods. In
order to have enough genes for the comparison between different methods,
all the co-expression modules for the robustness evaluation were selected by
including more than 5 genes. The diagonal of the table indicates the numbers
of the total genes in each method; the lower triangular matrix shows the
numbers of overlapping genes between the corresponding two methods; the
upper triangular matrix shows the hypergeometric p-values for the numbers
of overlapping genes. Figure S5. Each panel represents a single 8-cell
blastomeres top 25 network modules (columns) and the top 10 centrally
connected genes within each module. Blastomere networks and modules
identified using the absolute expression values of 8-cell blastomeres. Modules
are ranked in order from most (left) to least (right) centrally connected within
the specific blastomere network. The most centrally connected gene within
each module are shown in bold and the remaining genes are ranked from
most (top) to least (bottom) centrally connected within a specific module. Blue
highlighted genes are also identified as upstream regulatory genes.
Figure S6. qPCR expression (ΔCt) of Hippo signalling, pluripotency and
polarity genes across three sets of 8-cell blastomeres. The first set of
blastomers are labelled A1-A8, the second set of blastomeres are labelled
B1-B8 and the final set of blastomeres are labelled C1-C8. ΔCt was calculated
as 40-Ct. Positive and negative bars represent standard error of the mean.
Figure S7. Heat map of individual 8-cell blastomere RNAseq data extracted
from Petropoulos et al. Heatmap displays individual 8-cell blastomeres on the
horizontal axis and genes on the vertical axis. Individual blastomeres are
clustered according to gene expression similarity. After outlier removal we
used 59 of the 81 published samples. Embryo origin normalised and variance
filter applied (0.21) to exclude noise. Resulting in 588 probes, separated into
four groups based on hierarchal clustering. Red represents increased gene
expression and blue represents decreased gene expression. (PPTX 6500 kb)
Additional file 3: Supplemental Tables (XLSX 274 kb)
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